Human Genome Epidemiology Literature Finder
|
Records 1 - 13 (of 13 Records) |
| Query Trace: Disease and BIRC3[original query] |
|---|
| Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting. Haematologica 2015 Mar 100 (3): 370-6. Sutton Lesley-Ann, Ljungström Viktor, Mansouri Larry, Young Emma, Cortese Diego, Navrkalova Veronika, Malcikova Jitka, Muggen Alice F, Trbusek Martin, Panagiotidis Panagiotis, Davi Frederic, Belessi Chrysoula, Langerak Anton W, Ghia Paolo, Pospisilova Sarka, Stamatopoulos Kostas, Rosenquist Richa |
| Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans. Oncotarget 2015 Mar 6 (7): 5426-34. Xia Yi, Fan Lei, Wang Li, Gale Robert Peter, Wang Man, Tian Tian, Wu Wei, Yu Liang, Chen Yao-Yu, Xu Wei, Li Jian-Yo |
| BIRC3 single nucleotide polymorphism associate with asthma susceptibility and the abundance of eosinophils and neutrophils. The Journal of asthma : official journal of the Association for the Care of Asthma 2016 Jun 1-9. Roscioli Eugene, Hamon Rhys, Ruffin Richard E, Grant Janet, Hodge Sandra, Zalewski Peter, Lester Sus |
| Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin. Molecular cytogenetics 2018 1 11 6. La Starza Roberta, Pierini Tiziana, Pastorino Lorenza, Albi Elisa, Matteucci Caterina, Crescenzi Barbara, Sportoletti Paolo, Covarelli Piero, Falzetti Franca, Roti Giovanni, Ascani Stefano, Mecucci Cristi |
| Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial. Leukemia 2020 2 34 (7): 1760-1774. Blakemore Stuart J, Clifford Ruth, Parker Helen, Antoniou Pavlos, Stec-Dziedzic Ewa, Larrayoz Marta, Davis Zadie, Kadalyayil Latha, Colins Andrew, Robbe Pauline, Vavoulis Dimitris, Forster Jade, Carr Louise, Morilla Ricardo, Else Monica, Bryant Dean, McCarthy Helen, Walewska Renata J, Steele Andrew J, Chan Jacqueline, Speight Graham, Stankovic Tanja, Cragg Mark S, Catovsky Daniel, Oscier David G, Rose-Zerilli Matthew J J, Schuh Anna, Strefford Jonathan |
| Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib. European journal of haematology 2020 Nov . Machnicki Marcin M, Górniak Patryk, P?pek Monika, Szymczyk Agnieszka, Iskierka-Ja?d?ewska El?bieta, Steckiewicz Pawe?, Bluszcz Aleksandra, Rydzanicz Ma?gorzata, Hus Marek, P?oski Rafa?, Makuch-?asica Hanna, Nowak Gra?yna, Juszczy?ski Przemys?aw, Jamroziak Krzysztof, Stok?osa Tomasz, Pu?a Barto |
| Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1. Haematologica 2020 Jan 105 (10): 2440-2447. Tausch Eugen, Beck Philipp, Schlenk Richard F, Jebaraj Billy J, Dolnik Anna, Yosifov Deyan Y, Hillmen Peter, Offner Fritz, Janssens Ann, Babu Govind K, Grosicki Sebastian, Mayer Jiri, Panagiotidis Panagiotis, McKeown Astrid, Gupta Ira V, Skorupa Alexandra, Pallaud Celine, Bullinger Lars, Mertens Daniel, Döhner Hartmut, Stilgenbauer Steph |
| Allelic Expression Imbalance Analysis Identified YAP1 Amplification in p53- Dependent Osteosarcoma. Cancers 2021 4 13 (6): . Niu Guanglin, Bak Agnieszka, Nusselt Melanie, Zhang Yue, Pausch Hubert, Flisikowska Tatiana, Schnieke Angelika E, Flisikowski Krzyszt |
| Characterization of DLBCL with a PMBL gene expression signature. Blood 2021 3 138 (2): 136-148. Duns Gerben, Viganò Elena, Ennishi Daisuke, Sarkozy Clementine, Hung Stacy S, Chavez Elizabeth, Takata Katsuyoshi, Rushton Christopher, Jiang Aixiang, Ben-Neriah Susana, Woolcock Bruce W, Slack Graham W, Hsi Eric D, Craig Jeffrey W, Hilton Laura K, Shah Sohrab P, Farinha Pedro, Mottok Anja, Gascoyne Randy D, Morin Ryan D, Savage Kerry J, Scott David W, Steidl Christi |
| Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesis. Pathology 2022 11 55 (1): 104-112. Coombes Caitlin, Horikawa Keisuke, Jain Sanjiv, Jiang Simon, Lim Jun Hee, Saxena Kartik, Shadbolt Bruce, Smyth Lillian, Tobin Joshua, Talaulikar Dip |
| Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell Carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 2 100150. Dogan Snjezana, Xu Bin, Rana Satshil, Chen Hui, Ghossein Ronald A, Berger Michael F, Ho Alan L, Katabi No |
| DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved. International journal of molecular sciences 2023 12 24 (24): . Natalya Risinskaya, Maria Gladysheva, Abdulpatakh Abdulpatakhov, Yulia Chabaeva, Valeriya Surimova, Olga Aleshina, Anna Yushkova, Olga Dubova, Nikolay Kapranov, Irina Galtseva, Sergey Kulikov, Tatiana Obukhova, Andrey Sudarikov, Elena Parovichniko |
| Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 11 OF1-OF8. Nitin Jain, Lisa J Croner, John N Allan, Tanya Siddiqi, Alessandra Tedeschi, Xavier C Badoux, Karl Eckert, Leo W K Cheung, Anwesha Mukherjee, James P Dean, Edith Szafer-Glusman, John F Seymo |
- Page last reviewed:Feb 1, 2024
- Content source: